166 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd
5 Jun 24
Current report (foreign)
4:16pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
30 May 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
19 Mar 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
15 Mar 24
Current report (foreign)
9:13am
6-K
GLMD
Galmed Pharmaceuticals Ltd
22 Nov 23
Current report (foreign)
4:05pm
6-K
8hidg
20 Nov 23
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
4:37pm
6-K
rwhkmth0u7g3h0hdbs
26 Sep 23
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
8:51am
6-K
oqnvrti7kcrke04r
22 Sep 23
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K/A
kaxqfqh
21 Sep 23
Current report (foreign) (amended)
7:30am
6-K
iq9z3vizhy8
20 Sep 23
Current report (foreign)
4:30pm
6-K
0l3 y4wn5pix
13 Sep 23
Current report (foreign)
4:01pm
6-K
otsh23wbgcxxu 7u3w
9 Aug 23
Current report (foreign)
4:43pm
6-K
c6yqwt2k8 akd4fiir
9 Aug 23
Current report (foreign)
4:30pm
6-K
4wlwin
2 Aug 23
Consolidated Financial Statements
4:30pm
6-K
mishb0y1486fw88xim5l
18 Jul 23
Current report (foreign)
9:25am
6-K
qvpbkpq
14 Jul 23
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
9:44am
6-K
k7ehujl
10 Jul 23
Current report (foreign)
8:10am
6-K
c6a1jed9mc590aahf
1 Jun 23
Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results
8:14am
6-K
zl12u zpr
12 May 23
Current report (foreign)
7:00am
6-K
f64dak5b
11 May 23
Current report (foreign)
4:15pm